Details for New Drug Application (NDA): 214768
✉ Email this page to a colleague
The generic ingredient in TRIAMTERENE is hydrochlorothiazide; triamterene. There are thirty-two drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; triamterene profile page.
Summary for 214768
Tradename: | TRIAMTERENE |
Applicant: | Hibrow Hlthcare |
Ingredient: | triamterene |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 214768
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 50MG | ||||
Approval Date: | Jul 6, 2022 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 100MG | ||||
Approval Date: | Jul 6, 2022 | TE: | RLD: | No |
Complete Access Available with Subscription